229 related articles for article (PubMed ID: 8578847)
1. Specific secretory immune responses in the female genital tract following intranasal immunization with a recombinant adenovirus expressing glycoprotein B of herpes simplex virus.
Gallichan WS; Rosenthal KL
Vaccine; 1995 Nov; 13(16):1589-95. PubMed ID: 8578847
[TBL] [Abstract][Full Text] [Related]
2. Effects of the estrous cycle on local humoral immune responses and protection of intranasally immunized female mice against herpes simplex virus type 2 infection in the genital tract.
Gallichan WS; Rosenthal KL
Virology; 1996 Oct; 224(2):487-97. PubMed ID: 8874509
[TBL] [Abstract][Full Text] [Related]
3. Mucosal immunity and protection after intranasal immunization with recombinant adenovirus expressing herpes simplex virus glycoprotein B.
Gallichan WS; Johnson DC; Graham FL; Rosenthal KL
J Infect Dis; 1993 Sep; 168(3):622-9. PubMed ID: 8354903
[TBL] [Abstract][Full Text] [Related]
4. Intravaginal immunization with viral subunit protein plus CpG oligodeoxynucleotides induces protective immunity against HSV-2.
Kwant A; Rosenthal KL
Vaccine; 2004 Aug; 22(23-24):3098-104. PubMed ID: 15297061
[TBL] [Abstract][Full Text] [Related]
5. Challenges for vaccination against sexually-transmitted diseases: induction and long-term maintenance of mucosal immune responses in the female genital tract.
Rosenthal KL; Gallichan WS
Semin Immunol; 1997 Oct; 9(5):303-14. PubMed ID: 9327525
[TBL] [Abstract][Full Text] [Related]
6. Intranasal immunization with CpG oligodeoxynucleotides as an adjuvant dramatically increases IgA and protection against herpes simplex virus-2 in the genital tract.
Gallichan WS; Woolstencroft RN; Guarasci T; McCluskie MJ; Davis HL; Rosenthal KL
J Immunol; 2001 Mar; 166(5):3451-7. PubMed ID: 11207303
[TBL] [Abstract][Full Text] [Related]
7. Long-term immunity and protection against herpes simplex virus type 2 in the murine female genital tract after mucosal but not systemic immunization.
Gallichan WS; Rosenthal KL
J Infect Dis; 1998 May; 177(5):1155-61. PubMed ID: 9592997
[TBL] [Abstract][Full Text] [Related]
8. Induction of mucosal immunity against herpes simplex virus by plasmid DNA immunization.
Kuklin N; Daheshia M; Karem K; Manickan E; Rouse BT
J Virol; 1997 Apr; 71(4):3138-45. PubMed ID: 9060677
[TBL] [Abstract][Full Text] [Related]
9. Prolonged exposure to progesterone prevents induction of protective mucosal responses following intravaginal immunization with attenuated herpes simplex virus type 2.
Gillgrass AE; Ashkar AA; Rosenthal KL; Kaushic C
J Virol; 2003 Sep; 77(18):9845-51. PubMed ID: 12941893
[TBL] [Abstract][Full Text] [Related]
10. Nasal and skin delivery of IC31(®)-adjuvanted recombinant HSV-2 gD protein confers protection against genital herpes.
Wizel B; Persson J; Thörn K; Nagy E; Harandi AM
Vaccine; 2012 Jun; 30(29):4361-8. PubMed ID: 22682292
[TBL] [Abstract][Full Text] [Related]
11. Differential induction of mucosal and systemic antibody responses in women after nasal, rectal, or vaginal immunization: influence of the menstrual cycle.
Kozlowski PA; Williams SB; Lynch RM; Flanigan TP; Patterson RR; Cu-Uvin S; Neutra MR
J Immunol; 2002 Jul; 169(1):566-74. PubMed ID: 12077289
[TBL] [Abstract][Full Text] [Related]
12. Protection against genital herpes infection in mice immunized under different hormonal conditions correlates with induction of vagina-associated lymphoid tissue.
Gillgrass AE; Tang VA; Towarnicki KM; Rosenthal KL; Kaushic C
J Virol; 2005 Mar; 79(5):3117-26. PubMed ID: 15709031
[TBL] [Abstract][Full Text] [Related]
13. Immunization with HSV-2 gB-CCL19 Fusion Constructs Protects Mice against Lethal Vaginal Challenge.
Yan Y; Hu K; Deng X; Guan X; Luo S; Tong L; Du T; Fu M; Zhang M; Liu Y; Hu Q
J Immunol; 2015 Jul; 195(1):329-38. PubMed ID: 25994965
[TBL] [Abstract][Full Text] [Related]
14. Intranasal immunization of mice with herpes simplex virus type 2 recombinant gD2: the effect of adjuvants on mucosal and serum antibody responses.
Ugozzoli M; O'Hagan DT; Ott GS
Immunology; 1998 Apr; 93(4):563-71. PubMed ID: 9659230
[TBL] [Abstract][Full Text] [Related]
15. Mucosal inoculation of Lactobacillus expressing hCGbeta induces an anti-hCGbeta antibody response in mice of different strains.
Yao XY; Yuan MM; Li DJ
Methods; 2006 Feb; 38(2):124-32. PubMed ID: 16414267
[TBL] [Abstract][Full Text] [Related]
16. Mucosal immunization with inactivated HIV-1-capturing nanospheres induces a significant HIV-1-specific vaginal antibody response in mice.
Akagi T; Kawamura M; Ueno M; Hiraishi K; Adachi M; Serizawa T; Akashi M; Baba M
J Med Virol; 2003 Feb; 69(2):163-72. PubMed ID: 12683403
[TBL] [Abstract][Full Text] [Related]
17. Intranasal immunization with plasmid DNA-lipid complexes elicits mucosal immunity in the female genital and rectal tracts.
Klavinskis LS; Barnfield C; Gao L; Parker S
J Immunol; 1999 Jan; 162(1):254-62. PubMed ID: 9886393
[TBL] [Abstract][Full Text] [Related]
18. Mucosal immunity to HIV-1: systemic and vaginal antibody responses after intranasal immunization with the HIV-1 C4/V3 peptide T1SP10 MN(A).
Staats HF; Nichols WG; Palker TJ
J Immunol; 1996 Jul; 157(1):462-72. PubMed ID: 8683152
[TBL] [Abstract][Full Text] [Related]
19. Immunity to vaginal infection by herpes simplex virus type 2 in adult mice: characterization of the immunoglobulins in vaginal mucus.
Parr EL; Bozzola JJ; Parr MB
J Reprod Immunol; 1998 Apr; 38(1):15-30. PubMed ID: 9616875
[TBL] [Abstract][Full Text] [Related]
20. Immunity to vaginal HSV-2 infection in immunoglobulin A knockout mice.
Parr MB; Harriman GR; Parr EL
Immunology; 1998 Oct; 95(2):208-13. PubMed ID: 9824477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
